BENEFIT OF PROLONGED FILGOTINIB DOSING IN PATIENTS WITH ULCERATIVE COLITIS WHO DID NOT RESPOND TO INDUCTION THERAPY: DATA FROM THE SELECTION LONG-TERM EXTENSION STUDY

Severine Vermeire  1     Toshifumi Hibi  2     Alessandra Oortwijn  3     Simon Hatch  4     Silvio Danese  5     Brian G. Feagan  6     William Sandborn  7    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
2 Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
3 Galapagos NV, Leiden, Netherlands
4 Galapagos Inc., Waltham, MA, United States
5 IBD Center, Humanitas Research Hospital, Milan, Italy
6 Robarts Research Institute, Western University, London, ON, Canada
7 University of California San Diego, La Jolla, CA, United States

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing